Ryusuke Murakami
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in
-
- Ovarian cancer diagnosis and treatment 23
- Oncology 21
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Masaki Mandai (59 shared papers)Junzo Hamanishi (46 shared papers)Ken Yamaguchi (46 shared papers)Noriomi Matsumura (35 shared papers)Tsukasa Baba (34 shared papers)Kaoru Abiko (35 shared papers)Ikuo Konishi (29 shared papers)Naoki Horikawa (9 shared papers)
- Journals
- Gynecologic Oncology (6 papers)Journal of Gynecologic Oncology (5 papers)International Journal of Clinical Oncology (4 papers)Cancer Research (3 papers)BMC Cancer (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ryusuke Murakami
70 papers receiving 2.3k citations
Ryusuke Murakami's Hit Papers
Peers
Comparison fields: 5 of 89
- Reproductive Medicine 372
- Oncology 1.1k
- Immunology 860
- Obstetrics and Gynecology 170
- Cancer Research 291
Countries citing papers authored by Ryusuke Murakami
This map shows the geographic impact of Ryusuke Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryusuke Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryusuke Murakami more than expected).
Fields of papers citing papers by Ryusuke Murakami
This network shows the impact of papers produced by Ryusuke Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryusuke Murakami. The network helps show where Ryusuke Murakami may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryusuke Murakami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer Hit paper breakdown → | 2015 | 579 |
| 2 | Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition Hit paper breakdown → | 2021 | 243 |
| 3 | 2018 | 236 | |
| 4 | 2013 | 193 | |
| 5 | 2018 | 162 | |
| 6 | 2017 | 103 | |
| 7 | 2016 | 77 | |
| 8 | 2020 | 74 | |
| 9 | 2014 | 66 | |
| 10 | 2015 | 49 | |
| 11 | 2021 | 41 | |
| 12 | 2018 | 38 | |
| 13 | 2014 | 31 | |
| 14 | 2015 | 31 | |
| 15 | 2016 | 28 | |
| 16 | 2021 | 24 | |
| 17 | 2014 | 22 | |
| 18 | 2016 | 21 | |
| 19 | 2019 | 18 | |
| 20 | 2014 | 17 |
About Ryusuke Murakami
Ryusuke Murakami is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 82 papers that have together received 2.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (14 papers), Cancer Immunotherapy and Biomarkers (11 papers), Renal cell carcinoma treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Uterine Myomas and Treatments (4 papers), Chromatin Remodeling and Cancer (4 papers) and Cervical Cancer and HPV Research (3 papers). The work is most often cited by research in Reproductive Medicine (372 citations), Oncology (1.1k citations), Immunology (860 citations), Obstetrics and Gynecology (170 citations) and Cancer Research (291 citations). Ryusuke Murakami has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masaki Mandai, Junzo Hamanishi, Ken Yamaguchi, Noriomi Matsumura, Tsukasa Baba, Kaoru Abiko, Ikuo Konishi, Naoki Horikawa, Yumiko Yoshioka and Mana Taki. Their work appears in journals such as Gynecologic Oncology, Journal of Gynecologic Oncology, International Journal of Clinical Oncology, Cancer Research and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.